$GWPH Announces Second Positive Phase 3 Pivotal Trial for Epidiolex®

GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for Epidiolex® (cannabidiol)…

The Cannabis Industry Seems to Be Controlling the Extreme Use of Opioids

In states where medical marijuana is legal, a new study finds that…

Could This be the End of Mississippi’s Medical Marijuana Research Program

Many activists, investigative researchers, and supporters let out a collective cry when…

FDA Study Indicates Inconsistencies in Labeling of Cannabidiol Products Sold

With the recent sanctioning of cannabis items for either therapeutic or recreational…

FDA Allows the Access to CBD Treatment for AIDS and Cancer Patients

The U.S. Food and Drug Administration is one of the primary barriers…